Inventor
Shinji Kakimoto
Inventor
Kobe, JP
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides31%
C12NMicroorganisms or enzymes31%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture19%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations6%
C07CAcyclic or carbocyclic compounds6%
C12YEnzymes6%
PatentTitleYear
10,604,779Method for production of mutant-type human erythropoietin202010,557,115Medium containing uridine and N-acetyl-D-mannosamine202010,273,448Medium containing uridine and N-acetyl-D-mannosamine20199,657,310'Expression vector'20177,745,596'Nuclear transport nucleic acid delivery vector'20105,302,761'Tetrabromobisphenol A having a large particle size and process for its production'1994Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1994Patents assigned to TOSOH CORP (1)· patent assignee history
1994Based in Shinnanyo, US· patent location history
2010Patents assigned to JAPAN SCIENCE & TECH AGENCY (1)· patent assignee history
2010Based in Osaka, JP· patent location history
2017–2020Patents assigned to JAPAN CHEM RES (4)· patent assignee history
2017Based in Hyogo, JP· patent location history
2019–2020Based in Kobe, JP· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| JAPAN CHEM RES | 4 | 2017–2020 |
| JAPAN SCIENCE & TECH AGENCY | 1 | 2010 |
| TOSOH CORP | 1 | 1994 |
Locations
| Location | Patents | Span |
|---|---|---|
| Kobe, JP | 3 | 2019–2020 |
| Hyogo, JP | 1 | 2017 |
| Osaka, JP | 1 | 2010 |
| Shinnanyo, US | 1 | 1994 |